Roel van Kampen

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò et al. · Leukemia · 2021 · 94 citations · Full text

Medicine, Internal Medicine, Oncology +14

Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL

Marco V. Haselager, Rachel Thijssen, Christopher M. West et al. · Cell Death and Differentiation · 2021 · 87 citations · Full text

Life Sciences, Cancer Biology, Pharmacology +13

Functional status decline in older patients with breast and colorectal cancer after cancer treatment: A prospective cohort study

Doris van Abbema, Arnée van Vuuren, Franchette van den Berkmortel et al. · Journal of Geriatric Oncology · 2017 · 78 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

Janet R. Vos, Ingrid E. Fakkert, Joanne A. de Hullu et al. · JNCI Journal of the National Cancer Institute · 2019 · 69 citations · Full text

Medicine, Genetics, Oncology +17

CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

Anne W. J. Martens, Susanne R. Janssen, Ingrid A. M. Derks et al. · Journal for ImmunoTherapy of Cancer · 2020 · 23 citations · Full text

Medicine, Immunology, Oncology +17